California Cancer Reporting System Standards Volume I: Abstracting and Coding Procedures
Enter the findings from the laboratory tests or procedures used in establishing the diagnoses of neoplasms or metastases, such as serum protein electrophoresis for multiple myeloma or Waldenstrom's macroglobulinemia, serum alpha fetoprotein (AFP) for liver cancer, and other tumor marker studies.
Documentation for this text field should include:
Date of test
Use either a slash (/) or hyphen (-) to separate month, day, and year.
Test type
Test value (with range)
Interpretation (elevated, borderline, or normal).
Enter the name of the test to identify the test performed (do not state "SSF 1-25" to identify the test).
Use standard medical abbreviations when possible. See Appendices M.1 and M.2 for common acceptable abbreviations
Use phrases not complete sentences. Separate phrases using either periods (.) or semi-colons (:).
Avoid using only uppercase/capitals in text documentation.
Record T-and B-cell marker studies on leukemias and lymphomas, but enter hematology reports for leukemia and myeloma under Pathology.
In leukemia cases where both bone marrow and chromosomes are analyzed, the bone marrow results take precedence in coding histologic type, unless more specific information is given in the cytogenetic report. See Section IV.2.
Subcategories of acute myeloid leukemia are described according to cytogenetic abnormalities. If these abnormalities are included in a laboratory report, they take precedence in coding histologic type.
Record chromosome study or cytogenetic and molecular biological data results here. Enter "none" if no pertinent laboratory tests were performed.
Use the term "none" if no laboratory tests were performed.